STOCK TITAN
  1. Home
  2. Sec-filings
  3. KMTS
  4. [144] KESTRA MEDICAL TECHNOLOGIES, LTD. SEC Filing

Kestra Medical Technologies (KMTS) insider schedules 13,017-share stock sale

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

KESTRA MEDICAL TECHNOLOGIES, LTD. reports a planned sale of 13,017 shares of common stock through Merrill Lynch on July 31, 2026, listed on NASDAQ. These shares were acquired on July 17, 2026 as a performance stock issuance granted under the issuer’s equity compensation plan. Over the prior three months, reporting person Brian Webster sold multiple blocks of common shares, including 15,000-share transactions on April 15, May 15, June 15, and July 15, 2026, and additional sales of 7,857 and 8,948 shares on July 30 and July 31, 2026, respectively, each with stated aggregate sale values.

Positive

  • None.

Negative

  • None.
Planned shares to be sold 13,017 shares Common stock sale scheduled for July 31, 2026 through Merrill Lynch on NASDAQ
Date shares were granted 07/17/2026 Performance stock issuance under issuer equity compensation plan
Sale on April 15, 2026 15,000 shares; $300,671.04 Common shares sold by Brian Webster on 04/15/2026
Sale on May 15, 2026 15,000 shares; $314,329.85 Common shares sold by Brian Webster on 05/15/2026
Sale on June 15, 2026 15,000 shares; $312,142.94 Common shares sold by Brian Webster on 06/15/2026
Sale on July 15, 2026 15,000 shares; $336,609.41 Common shares sold by Brian Webster on 07/15/2026
Sale on July 30, 2026 7,857 shares; $178,531.04 Common shares sold by Brian Webster on 07/30/2026
Sale on July 31, 2026 8,948 shares; $202,259.77 Common shares sold by Brian Webster on 07/31/2026
Form 144 regulatory
"144: Securities To Be Sold Common Stock"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.
performance stock issuance financial
"07/17/2026 | Performance Stock Issuance | KESTRA"
equity compensation plan financial
"Granted as part of issuer equity compensation plan"
A plan by which a company gives employees, directors or contractors ownership or the right to buy ownership in the company through stock, options or similar awards — think of promising slices of the company pie as part of someone's pay. It matters to investors because these awards can change the number of shares outstanding, affect reported profits and influence management’s decisions; large or generous plans can dilute existing holders and alter incentives over time.
common shares financial
"Common Shares | 04/15/2026 | 15000"
Common shares are the basic units of ownership in a company that give holders a claim on profits and a right to vote on key matters, like electing the board. Think of them as membership cards in a club: they let you share in successes and losses, but in a bankruptcy or liquidation they are paid after creditors and preferred shareholders, so their value can swing more and matters for assessing risk and potential return.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

FAQ

What does KESTRA MEDICAL TECHNOLOGIES (KMTS) disclose in this Form 144?
The company discloses a planned sale of 13,017 common shares on July 31, 2026, acquired via a performance stock issuance granted under its equity compensation plan, along with a history of prior share sales over the preceding three months.

How many KMTS shares are planned to be sold and through which broker?
A total of 13,017 common shares are planned to be sold through Merrill Lynch at 225 Liberty Street, New York, NY 10281, with the shares listed on NASDAQ and scheduled for sale on July 31, 2026.

How were the KMTS shares to be sold on July 31, 2026 obtained?
The 13,017 shares to be sold on July 31, 2026 were obtained through a performance stock issuance on July 17, 2026, granted as part of KESTRA MEDICAL TECHNOLOGIES, LTD.’s issuer equity compensation plan.

What prior KMTS share sales by Brian Webster are disclosed?
Brian Webster is reported to have sold 15,000 shares on each of April 15, May 15, June 15, and July 15, 2026, plus 7,857 shares on July 30, 2026 and 8,948 shares on July 31, 2026, each with stated aggregate dollar values.

What total dollar values are shown for recent KMTS share sales?
The disclosed aggregate values include $300,671.04 (April 15, 2026), $314,329.85 (May 15, 2026), $312,142.94 (June 15, 2026), $336,609.41 (July 15, 2026), $178,531.04 (July 30, 2026), and $202,259.77 (July 31, 2026) for the respective share sales.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Source: View Original Filing on SEC EDGAR